EUCTR2011-004177-83-NL
Active, not recruiting
Not Applicable
Boosting the oxytocin system in acute trauma: The effectiveness of intranasal oxytocin treatments and stimulation of social support on preventing trauma related psychopathology - Oxytocin and social support as early interventions in acute trauma
Academic Medical Center0 sitesSeptember 7, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV
- Sponsor
- Academic Medical Center
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Presentation at the Trauma Unit or Emergency Department after a potential traumatic event, according to PTSD A1 criterion in the DSM\-IV
- •?Trauma Screening Questionnaire (TSQ) \> 5 between 24 and 72 hours after trauma exposure
- •?Age 18 – 65 years
- •?Significant other (i.e. best friend, partner or family member) willing to join the social support intervention
- •?Capable to read and comprehend either the Dutch or English language
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 260
- •F.1\.3 Elderly (\>\=65 years) no
Exclusion Criteria
- •?Any severe or chronic systemic disease
- •?Current psychotic, bipolar, substance\-related, severe personality disorder, or mental retardation
- •?Current severe depressive disorder
- •?Prominent current suicidal risk or homicidal ideation
- •?Severe cognitive impairment or a history of organic mental disorder
- •?Evidence of PTSD or depression immediately prior to the index trauma
- •?History of neurological disorders (e.g., traumatic brain injury, seizure history)
- •?Reports of ongoing traumatization (e.g., in case of partner violence as index adult trauma)
- •?Evidence of clinically significant and unstable medical conditions in which OT administration is contra\-indicative such as cardiovascular, gastro\-intestinal, pulmonary, severe renal, endocrine or hematological disorders, glaucoma, history of epilepsy, or a stroke or myocardial infarction within the past year
- •?Use of prostaglandins and certain anti\-migraine medications (ergot alkaloids)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Boosting oxytocin after trauma: The effects of intranasal oxytocin administration on emotional and motivational brain processes in PTSDposttraumatic stress disorder (PTSD) and stress disorder10002861NL-OMON39817Academisch Medisch Centrum83
Active, not recruiting
Not Applicable
The effect of oxytocin in PTSDEUCTR2012-001288-58-NLAcademic Medical Center
Completed
Not Applicable
The effect of oxytocin on brain processes in PTSD.Posttraumatic stress disorder (PTSD), Oxytocin, NeuroimagingNL-OMON20321Academic Medical Center (AMC)80
Completed
Phase 2
Boosting Oxytocin after trauma: Neurobiology and the Development of Stress-related symptoms.posttraumatic stress disorder (PTSD) and stress disorder10002861NL-OMON39401Academisch Medisch Centrum124
Completed
Not Applicable
Boosting oxytocin after trauma.PTSD, trauma-related psychopathologyNL-OMON27745Academic Medical Center - University of Amsterdam220